Dan Wagner

Dan Wagner is the current Director at Biorez. Prior to their current position, they were the Sr. Managing Director, Investments at Connecticut Innovations for 3 years and 10 months. Dan also served as a Board Observer for Tastes Natural, LLC for 1 year and 2 months, BEKHealth for 1 year, Artizan Biosciences, Inc. for 1 year and 6 months, Simcha Therapeutics for 2 years and 8 months, and Azitra Inc for 4 years and 2 months. Furthermore, they were a Board Member for Biorez for 6 years and 5 months, Tangen Biosciences, Inc. for 6 years and 6 months, and IsoPlexis for 7 years and 11 months. Lastly, they were a Board Observer for P2 Science, Inc. for 9 years and 3 months.

Dan Wagner has a Master of Business Administration from Quinnipiac University, a Venture Capital Institute 2008 certification, and a Master of Health Sciences from Quinnipiac University. Dan also has a degree in Biology from the University of Dayton.